Whether it’s research into cancer, infection, immunity, the neurosciences, novel methodologies and more— biologists, biochemists, and medicinal chemistry researchers around the world are getting their work noticed by publishing in ACS Omega, a global, multidisciplinary, fully open-access journal from the American Chemical Society (ACS) and ACS Publications. That’s because ACS Publications is a nonprofit scholarly […]
Whether it’s research into cancer, infection, immunity, the neurosciences, novel methodologies and more— biologists, biochemists, and medicinal chemistry researchers around the world are getting their work noticed by publishing in ACS Omega, a global, multidisciplinary, fully open-access journal from the American Chemical Society (ACS) and ACS Publications.
That’s because ACS Publications is a nonprofit scholarly publisher committed to publishing high-quality research and— like all ACS journals— ACS Omega is led by a team of Editors who are also prominent practicing scientists. These Editors, who are experts in their fields, oversee a thorough, fair, and constructive peer-review process.
- Professor Krishna Ganesh, Indian Institute of Science Education and Research, focusing on modified DNA and peptide-nucleic acids as novel cell-penetrating agents
- Professor Jesús Jiménez-Barbero, CIC bioGUNE, who focuses on unraveling the molecular basis of the recognition of glycans by receptors in solution
- Professor Swagata Dasgupta, IIT Kharagpur, who focuses on protein-ligand binding, protein isolation and characterization, and protein structure analyses
- Professor Jeehiun Lee, Rutgers University, who focuses on biological and organic catalysis
- Professor Eriko Takano, University of Manchester, who focuses on small signaling molecules in Streptomyces coelicolor, the model organism of the major group of commercial antibiotic producers
That level of expertise means articles are being evaluated by Editors who know their field and can move quickly to publish important work. Publishing quickly helps ACS Omega articles reach a wide audience and attract citations.
Check out some highly-cited biochemistry and medicinal chemistry articles published in ACS Omega.
Beyond the Antagonism: Self-Labeled Xanthone Inhibitors as Modeled “Two-in-One” Drugs in Cancer Therapy
ACS Omega, 2017, 2, 3, 873-889
Synthesis of Novel Hybrids of Quinazoline and Artemisinin with High Activities against Plasmodium falciparum, Human Cytomegalovirus, and Leukemia Cells
ACS Omega, 2017, 2, 6, 2422-2431
Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect
ACS Omega, 2017, 2, 3, 937-945
Improved Solubility and Bioactivity of Camptothecin Family Antitumor Drugs with Supramolecular Encapsulation by Water-Soluble Pillararene
ACS Omega, 2017, 2, 8, 5283-5288
Impact of an N-terminal Polyhistidine Tag on Protein Thermal Stability
ACS Omega, 2018, 3, 1, 760-768
Potent Anticancer Activity with High Selectivity of a Chiral Palladium N-Heterocyclic Carbene Complex
ACS Omega, 2017, 2, 8, 4632-4646
Liquid Crystalline Nanostructures as PEGylated Reservoirs of Omega-3 Polyunsaturated Fatty Acids: Structural Insights toward Delivery Formulations against Neurodegenerative Disorders
ACS Omega, 2018, 3, 3, 3235-3247
Antibiotic Resistance: Current Perspectives
ACS Omega, 2017, 2, 10, 7400-7409
Enabling Biocatalysis by High-Throughput Protein Engineering Using Droplet Microfluidics Coupled to Mass Spectrometry
ACS Omega, 2018, 3, 2, 1498-1508
Discover highly-cited ACS Omega research in other popular categories:
Submitting research to ASC Omega is a fast, easy way to get your work noticed in a reputable global interdisciplinary journal from the publisher of the Journal of the American Chemical Society (JACS). The journal offers incredibly fast publication times, and the editors only evaluate the research itself, without making subjective decisions about its perceived impact. The journal publishes high-quality new findings, but also studies that demonstrate the reproducibility of existing research, along with large datasets, and noteworthy negative results. Plus, ACS Omega is 100% open access, helping your work reach new audiences in both industry and academia.